Sorriso Pharmaceuticals

San Diego, United States

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

$31.0M raised

Dec 2021

Series A

Biotechnology Pharmaceutical Therapeutics

Top Investors

New Enterprise AssociatesArix Bioscience

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sorriso Pharmaceuticals

How much funding has Sorriso Pharmaceuticals raised?

Sorriso Pharmaceuticals has raised $31.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Who are Sorriso Pharmaceuticals's investors?

Sorriso Pharmaceuticals's investors include New Enterprise Associates, Arix Bioscience.

Where is Sorriso Pharmaceuticals headquartered?

Sorriso Pharmaceuticals is headquartered in San Diego, United States.

What does Sorriso Pharmaceuticals do?

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

What stage is Sorriso Pharmaceuticals at?

Sorriso Pharmaceuticals is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 22, 2021.

MLA

"Sorriso Pharmaceuticals — Funding & Investors." VCBacked, December 22, 2021, https://www.vcbacked.co/company/sorriso-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2021). Sorriso Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/sorriso-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Sorriso Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/sorriso-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 22, 2021.